Company Profile

Rhegen Bio

Rhegen Bio is a platform technology company applying cutting-edge life science and technology to develop innovative mRNA drugs and vaccines. Based on the unique advantages of our own mRNA platform technology, independently discovered innovative drug targets, independently developed drug synthesis methods and drug carrier platforms, Rhegen Bio has formed a product pipeline layout for a series of clinical indications such as functional protein defects, cancer and infectious diseases. It is one of the few biotech companies in the world that master mRNA core technology.